Canada · Safety & cost
Compounded vs generic vs brand-name GLP-1s in Canada
Applies to: Canada
By Joshua Nichvolodoff · Fact-checked against sources November 2, 2026 · Next review due January 31, 2027
Clinical review: not yet reviewed by a clinician. How review works · Editorial policy
In Canada, generic semaglutide is now authorized by Health Canada, but "compounded" GLP-1 products sold without a shortage are not permitted. These are very different things[1][2].
The three kinds of product
| Item | Authorized? | What it means |
|---|---|---|
| Brand-name (e.g. Ozempic, Wegovy) | Yes | Has a Health Canada product monograph |
| Generic (e.g. Sevmia, Apo-Semaglutide) | Yes | Pharmaceutically equivalent to the brand, per Health Canada |
| “Compounded” GLP-1 without a shortage | No | Not permitted; treated as unauthorized manufacturing |
Generic semaglutide
Health Canada authorized Sevmia, a generic of Wegovy, on June 29, 2026 — the third generic semaglutide it had approved — and said it was reviewing six other generic semaglutide submissions[1]. A generic of Ozempic is not a substitute for Wegovy: Medavie Blue Cross, for example, says generic Ozempic will not be approved as a substitute[5]. See generic semaglutide in Canada.
Compounded GLP-1 products
Health Canada's position is that some compounding pharmacies continue to prepare and sell injectable GLP-1 products in the absence of a shortage, which is not permitted; that outside of unique patient-specific cases it considers this manufacturing; and that no chemically synthesized semaglutide is authorized in Canada. It has requested the recall of two compounded semaglutide products[2].
Fake and unauthorized products
Health Canada warns about unauthorized and counterfeit GLP-1 products sold in stores and online, some misusing Health Canada's logo. Its enforcement includes seizures, warning letters and work with the Canada Border Services Agency[3].
General information, not medical or legal advice. Light Years does not link to or earn from any seller of any product named here.
Have a quote from your own pharmacy? Work out your monthly and yearly cost — it runs in your browser, and nothing you type is sent anywhere.
Sources
- Canada approves first generic semaglutide for weight loss. Health Canada, June 29, 2026. https://www.canada.ca/en/health-canada/news/2026/06/canada-approves-first-generic-semaglutide-for-weight-loss.html. Accessed November 2, 2026. Back to the text
- Health Canada's position on the unauthorized manufacturing of products sold as compounded GLP-1 receptor agonists. Health Canada (document hosted by the Ontario College of Pharmacists), June 2, 2025. https://ocpinfo.com/health-canada-position-glp-1/. Accessed November 2, 2026. Back to the text
- Thinking about buying GLP-1 drugs like Ozempic or Mounjaro? Beware of fake or unauthorized products. Health Canada (Recalls and Safety Alerts), January 21, 2026. https://recalls-rappels.canada.ca/en/alert-recall/thinking-about-buying-glp-1-drugs-ozempic-or-mounjaro-beware-fake-or-unauthorized. Accessed November 2, 2026. Back to the text
- WEGOVY (semaglutide injection) product monograph (authorized December 10, 2025). Health Canada Drug Product Database / Novo Nordisk Canada, December 10, 2025. https://pdf.hres.ca/dpd_pm/00082777.PDF. Accessed November 2, 2026. Back to the text
- Generic semaglutide (Ozempic) launch in Canada — FAQ. Medavie Blue Cross, 2026. https://docs.medaviebc.ca/advisors/MBC_Generic-Semaglutide_External-Individuals-FAQ_EN.pdf. Accessed November 2, 2026. Back to the text
Figures marked “as reported” are historical: they show what the source said on that date, not today's price or rule.
Changes to this page
- — First published.
Substantive corrections are also logged at corrections.